A carregar...
Disruption of insulin receptor function inhibits proliferation in endocrine resistant breast cancer cells
The insulin-like growth factor (IGF) system is a well-studied growth regulatory pathway implicated in breast cancer biology. Clinical trials testing monoclonal antibodies directed against the type I IGF receptor (IGF1R) in combination with estrogen receptor-α (ER) targeting have been completed, but...
Na minha lista:
| Publicado no: | Oncogene |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4982805/ https://ncbi.nlm.nih.gov/pubmed/26876199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2015.488 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|